Matthew Paul Larson, Slide Insurance Holdings' (NYSE:SLDE) Chief Risk Officer, reported an 11,250-share sale of common stock on March 24, 2026. The shares were sold at $18.00 apiece, producing gross proceeds of $202,500. At the time of the filing the stock was trading at $17.78, which is below InvestingPro's Fair Value estimate of $20.52, a valuation gap that the filing highlights.
The filing also discloses that on the same date Larson exercised options to purchase 11,250 shares at an exercise price of $0.79 per share. The exercise carried a cash cost of $8,887, and the acquired shares were subsequently sold in the open market. Both the option exercise and the share sale were reflected in the same-day reporting.
Slide Insurance's recent operating results provide context for the insider activity. The company reported diluted earnings per share of $3.36 over the last twelve months. In its fourth-quarter 2025 results, Slide Insurance posted earnings per share of $1.23, comfortably outpacing the consensus estimate of $0.71 - a 73.24% positive surprise versus expectations. Quarterly revenue for the period reached $347 million, up from $238.5 million in the comparable quarter a year earlier.
On the corporate finance front, Slide Insurance completed its initial $120 million stock repurchase program and authorized a follow-on buyback program totaling $125 million. These moves were accompanied by fresh analyst attention. Texas Capital Securities initiated coverage of Slide Insurance with a Buy rating and a $25 price target. Keefe, Bruyette & Woods adjusted its price target upward to $23 from $22, while maintaining an Outperform rating; that firm cited higher accretion from Citizens takeout activity and continued strength in loss trends as reasons for the revision.
The filings and corporate announcements together outline both an executive-level liquidity event and a broader set of financial developments: strong recent profitability on an LTM basis, an earnings beat in the latest quarter, completed and authorized share repurchases, and renewed analyst endorsements with higher price targets. The disclosure of the option exercise followed by an immediate sale is recorded alongside the transaction value and the company's published metrics.
Contextual note: The market price referenced in the filing ($17.78) is noted as being below InvestingPro's Fair Value estimate of $20.52. The company’s recently reported earnings performance and share repurchase activity are included in the regulatory and corporate disclosures linked to these insider and analyst updates.